#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Vitamin B12 deficiency Leiomyosarcoma recurrent Primary mediastinal large B-cell lymphoma Oropharyngeal cancer recurrent Adrenoleukodystrophy Langerhans' cell histiocytosis Multiple system atrophy Inclusion body myositis Hepatic cirrhosis Hyperchylomicronaemia Transitional cell carcinoma Acute promyelocytic leukaemia Renal cancer metastatic Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information Pelizaeus-Merzbacher disease – Trials in Disease Brain stem glioma Hereditary motor and sensory neuropathy – Life with Disease Cytokine release syndrome – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Basic Information Cystic fibrosis – Life with Disease Primary biliary cholangitis – Treatment Glomerulonephritis membranous – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Colchicine Losartan Potassium Meglumine Gadoterate Parsaclisib Hydrochloride Rbl012.2 Inavolisib Cetrimide Cusatuzumab Remimazolam Sodium Nitroprusside Dihydrate Cabazitaxel [18F] CANAGLIFLOZIN Alectinib Mecillinam Sertindole Siplizumab Chlorphenamine Perindopril Arginine Mr0005 Denosumab More therapies…

    Learn about Your Condition

    IgA nephropathy Thyroid mass Short-bowel syndrome Lupus nephritis Pyelonephritis Type 1 diabetes mellitus Neonatal asphyxia Small cell carcinoma Behcet's syndrome Fungal infection Erectile dysfunction Adrenoleukodystrophy Urethral valves Marginal zone lymphoma Dizziness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Trametinib
    France

  • Study on Fluasterone for Managing High Blood Sugar in Adults with Cushing’s Syndrome

    Recruiting

    2 1
    Investigated Diseases:
    • Cushing’s syndrome
    Investigated Drugs:
    • Fluasterone
    Greece

  • Study on the Effectiveness and Safety of NS-229 for Patients with Eosinophilic Granulomatosis with Polyangiitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Methyl-(1-{[6-{[(1S)-1-Cyclopropylethyl]Amino}-2-(Pyrazolo[5,1-B][1,3]Thiazol-7-Yl)-Pyrimidin-4-Yl]Carbonyl}Piperidin-4-Yl)Carbamate-Mono(4-Methylbenzenesulfonate) Monohydrate
    France Germany Italy Spain

  • Study on N-Acetyl-L-Leucine for Patients with Niemann-Pick Disease Type C

    Recruiting

    3 1
    Investigated Drugs:
    • L-Acetylleucine
    Czechia Germany The Netherlands Slovakia

  • Study of Denosumab Effects on Muscle Strength and Insulin Sensitivity in Patients with Postmenopausal Osteoporosis and Diabetes Mellitus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    • Diabetes mellitus
    Investigated Drugs:
    • Denosumab
    • Saline
    Denmark

  • Study on Glofitamab and Drug Combination for Children and Young Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Ifosfamide
    • Obinutuzumab
    Czechia Denmark France Germany Hungary Italy +2
Previous Page
1 … 456 457 458 459 460 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!